GTC
TBIO

Ghost Tree Capital’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Ghost Tree Capital’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,944
Closed -$390K – 69
2021
Q3 		$390K Hold
1,944
– – 0.11% 59
2021
Q2 		$770K Buy
+1,944
New +$687K 0.21% 52

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ghost Tree Capital's TBIO Position: Q4 2021 in Review

Ghost Tree Capital sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q4 2021, closing a stake of 1,944 shares — an estimated $390K sold.

Ghost Tree Capital first reported a position in TBIO in Q2 2021 and held it in 2 quarters. The position peaked at $770K in Q2 2021. 43 funds tracked by Wall St. Rank hold TBIO as of Q4 2021.

  • Ghost Tree Capital reported no remaining Telesis Bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Ghost Tree Capital sold 1,944 Telesis Bio, Inc. Common Stock shares in Q4 2021, an estimated $390K.
  • Ghost Tree Capital first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Ghost Tree Capital's Telesis Bio, Inc. Common Stock position peaked at $770K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q4 2021.

Based on Ghost Tree Capital's 13F filing for Q4 2021, filed 16 Feb 2022.